External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

Fusion Pharmaceuticals  / Equity Bottom-Up

<ul><li>Fusion Pharmaceuticals is being acquired by AstraZeneca for $21 in cash and a $3 CVR</li><li>Fusion presented promising results from its phase II trial, showing consistent safety signals</li><li>The acquisition demonstrates continued interest and investment in the biotech industry</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Fusion Pharmaceuticals is being acquired by AstraZeneca for $21 in cash and a $3 CVRFusion presented promising results from its phase II trial, showing consistent safety signalsThe acquisition demonstrates continued interest and investment in the biotech industryThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Fusion Pharmaceuti Inc (FUSN) - Wednesday, Apr 24, 2024

Canada

Fusion Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company discovers and develops novel targeted alpha therapeutics (TAT) and radiopharmaceuticals for the diagnosis and treatment of chemotherapy resistant cancers. Fusion Pharmaceuticals serves health care sectors in Canada.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Fusion Pharmaceuticals (FUSN US)

Fusion Pharmaceuti Inc (FUSN) - Wednesday, Apr 24, 2024

Fusion Pharmaceuticals is being acquired by AstraZeneca for $21 in cash and a $3 CVR. Fusion presented promising results from its phase II trial,...

Value Investors Club (VIC)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)